Abstract:See related article, pp 1719–1726 The article, "Racial/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013–2018," 1 by Dr Aggarwal and colleagues indicates that a contemporary understanding of racial and ethnic differences in the hypertension control cascade could inform targeted interventions to improve equity in blood pressure control. 2–4 Given the health and economic burden of hypertension and the lower rates of hypertension controlled to <140/<90 mm Hg in racial and ethnic minorities, 5,6 the report addresses a topic of epidemiological and clinical significance. The authors provide a clear and concise focus on the hypertension control cascade, including prevalence awareness, and treatment, in racial and ethnic minority groups as a strategy to inform health equity. In the process, they extend and confirm previous observations, for example, "Black Americans have the highest prevalence of hypertension, while rates of awareness and treatment are similar to White Americans". 2–4,6 Although the roughly 40% greater prevalence of hypertension in Black than White adults is not a direct contributor to disparities in control, it is a major factor underlying racial disparities in cardiovascular and renal outcomes. In other words, treatment and control of hypertension reduce but do not fully reverse the excess risk associated with hypertension, a phenomenon termed residual risk. 7 The authors note that adverse socioeconomic factors and structural racism limit access to healthy food and exercise options, which likely contribute to the greater burden of prevalent hypertension among Black than White Americans. 1,8 Their premise is consistent with the viewpoint that racial disparities in prevalent hypertension are more reflective of social than biological factors and consistent with reports that such disparities are not observed in more egalitarian societies. 9 Previous studies indicate that lesser treatment effectiveness, or a lower proportion of treated adults controlled, is the major factor underlying racial (Black-White) disparities in hypertension control. 2,10–12 Without specifically identifying treatment effectiveness as a driver of racial differences in hypertension control, the authors provide credible explanations for less effective antihypertensive treatment in Black adults including limited access to care and medications. They also cite evidence that providing care more directly from trusted community resources, for example, the successful barbershop study, represent effective approaches for improving hypertension control in Black men. 13 The explanation remains unclear on how adverse social determinants drive disparities between Black and White adults in prevalent hypertension and treatment effectiveness, while awareness and treatment are not different. A more granular understanding of specific social factors driving disparities in hypertension prevalence and treatment effectiveness between Black and White adults could inform targeted interventions for greater health equity. Hypertension control among treated adults in 2015 to 2018 was significantly lower among Black, Hispanic, and Asian than White Americans after adjusting for age, sex, and race and ethnicity. 12 Racial and ethnic differences in hypertension control among treated adults, that is, treatment effectiveness, remained significant for Black and Asian but not Hispanic Americans when education, income, type of health care insurance, having a usual source of health care and a health care visit in the past year were included in multivariable adjustment. 12 Similarly, the disparity in hypertension control between Hispanic and Black relative to White Americans in 2015 to 2018 appeared to be attenuated more after adjustment for education, obesity, and access to care in Hispanic (unadjusted and adjusted odds ratios 0.74 versus 0.98, respectively) than in Black Americans (0.79 versus 0.84, respectively). 14 These reports are consistent with the authors' viewpoint that social and structural factors affecting the control cascade vary across the different race-ethnicity subgroups and highlight the importance of more granular understanding to inform effective targeted interventions. 1 Hispanic Americans The authors indicate that prevalent hypertension is similar in Hispanic and White Americans, whereas awareness and treatment are lower. In fact, lower awareness and treatment rates in Hispanic than White Americans partially explain the ethnic disparity in hypertension control. 2,3,6,10,11 Lesser treatment effectiveness in Hispanic than White Americans contributes to inequities in hypertension control, 2 -Abstract Truncated-

Prevalence, Treatment, and Control of Hypertension Among US Women of Reproductive Age by Race/Hispanic Origin

Abstract 15896: Disparities in Awareness and Treatment Among Women With Hypertension: Insights From the American Heart Association Research Goes Red Registry

Disparities in Hypertension Prevalence, Awareness, Treatment, and Control Among Women Living With and Without HIV in the US South

Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018

Awareness, treatment, and control of hypertension among women at risk or living with HIV in the US South

Factors Associated With Hypertension Control in US Adults Using 2017 ACC/AHA Guidelines: National Health and Nutrition Examination Survey 1999–2016

Editorial commentary: Racial and Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018

Race/ethnicity differences in response to acute antihypertensive treatment of peripartum severe hypertension

Race/Ethnic Differences in Atherosclerotic Cardiovascular Disease Risk Factors Among Patients With Hypertension: Analysis From 143 Primary Care Clinics

Trends and Influence Factors in the Prevalence, Awareness, Treatment, and Control of Hypertension among US Adults from 1999 to 2018.

Public health and system approach in eliminating disparities in hypertensive disorders and cardiovascular outcomes in non-Hispanic Black women across the pregnancy life course

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014

Epidemiology of hypertension in African American women

Examining the Hypertension Control Cascade in Adults With Uncontrolled Hypertension in the US

Reducing Racial Disparities in HTN Control using an Equity-Centered Approach

Reprint of: Pharmacist-led hypertension management in a minority patient population

Abstract 16828: Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies From 90 Countries

Trends in prevalence of hypertension and high-normal blood pressure among US adults, 1999–2018

Hypertension Across a Woman's Life Cycle

Hypertension Prevalence, Treatment, and Control 90 Days After Acute Stroke Among Mexican American and Non-Hispanic White Adults

Hypertension Control Among US Adults, 2009 to 2012 Through 2017 to 2020, and the Impact of COVID-19